Orbital Therapeutics is a biotechnology company dedicated to advancing non-viral delivery systems for therapeutic applications, focusing primarily on RNA-based therapeutics. The organization develops and characterizes lipid nanoparticles (LNPs) and other non-viral delivery vehicles, aiming to enhance the efficiency and specificity of nucleic acid delivery to various cell and tissue types. Through a collaborative approach, Orbital brings together experts in research, automation, and manufacturing to promote the successful progression of its innovative pipeline. The company values a commitment to scientific excellence, teamwork, and adaptability, fostering an environment where employees can contribute to groundbreaking advancements in RNA technology and delivery systems.